Literature DB >> 177216

Expression of differentiative traits in the absence of cell fusion during myogenesis in culture.

S Adamo, B Zani, G Siracusa, M Molinaro.   

Abstract

Fusion of myoblasts is inhibited in cultures at low Ca++ concentration (0.44 mM); yet creatine phosphokinase and myokinase activities as well as myosin synthesis and the appearance of post-mitotic myoblasts do not significantly differ from those of control cultures (grown at 1.04 mM Ca++) which undergo cell fusion. When Ca++ concentration is increased to the control value after the second day of culture, fusion occurs very rapidly and it is not inhibited by actinomycin D or cycloheximide. Treatment with 0.06 mM bromodeoxyuridine strongly inhibits creatine phosphokinase activity and myotubes formation. The study of the kinetics of reversal of cell fusion and of creatine phosphokinase activity after removal of the analog, shows that this process is slower than the decrease of the relative content of bromodeoxyuridine incorporated into DNA. The result obtained support the following conclusions: a) the expression of the differentiative characters examined does not require cell fusion; b) the process of myotube formation seems to imply two subsequent stages consisting first of a slow maturative process, which is followed by the actual fusion of cell membranes; the former is Ca++ independent, the latter is Ca++ dependent and does not require RNA or protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177216     DOI: 10.1016/0045-6039(76)90015-4

Source DB:  PubMed          Journal:  Cell Differ        ISSN: 0045-6039


  10 in total

1.  Spontaneous channel activity induced by tumor promoter TPA in chick myotubes.

Authors:  C Ciccarelli; B M Zani; M Molinaro; F Grassi; F Eusebi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

2.  Acetylcholine regulation of nicotinic receptor channels through a putative G protein in chick myotubes.

Authors:  F Eusebi; F Grassi; M Molinaro; B M Zani
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

3.  Distinct effects of Rac1 on differentiation of primary avian myoblasts.

Authors:  R Gallo; M Serafini; L Castellani; G Falcone; S Alemà
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

4.  Activity and regulation of calcium-, phospholipid-dependent protein kinase in differentiating chick myogenic cells.

Authors:  S Adamo; C Caporale; C Nervi; R Ceci; M Molinaro
Journal:  J Cell Biol       Date:  1989-01       Impact factor: 10.539

5.  Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle.

Authors:  B G Novitch; G J Mulligan; T Jacks; A B Lassar
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

6.  A tribute to Professor Sergio Adamo, Full Professor of Histology and Embryology at Sapienza University, Rome.

Authors:  Bianca Maria Scicchitano; Marina Bouchè; Clara Nervi; Dario Coletti
Journal:  Eur J Transl Myol       Date:  2022-03-03

7.  The control of chick myoblast fusion by ion channels operated by prostaglandins and acetylcholine.

Authors:  A Entwistle; R J Zalin; S Bevan; A E Warner
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

8.  Agents that activate protein kinase C reduce acetylcholine sensitivity in cultured myotubes.

Authors:  F Eusebi; M Molinaro; B M Zani
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

Review 9.  Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle Homeostasis.

Authors:  Emeka K Enwere; Eric C Lacasse; Nadine J Adam; Robert G Korneluk
Journal:  Front Immunol       Date:  2014-02-05       Impact factor: 7.561

10.  Culture conditions influence satellite cell activation and survival of single myofibers.

Authors:  Alessandra Renzini; Anna Benedetti; Marina Bouchè; Leopoldo Silvestroni; Sergio Adamo; Viviana Moresi
Journal:  Eur J Transl Myol       Date:  2018-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.